KARS1 Gene Deafness Autosomal Recessive Type 89 Genetic Test sale cost 4400 AED
FOXI1 Gene Deafness Autosomal Recessive Type 4 Genetic Test sale cost 4400 AED FOXI1 Gene Deafness Autosomal Recessive Type 4 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
DNAI1 Gene Primary Ciliary Dyskinesia Type 1 Genetic Test sale cost 4400 AED DNAI1 Gene Primary Ciliary Dyskinesia Type 1 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

KARS1 Gene Deafness Autosomal Recessive Type 89 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The KARS1 Gene Deafness Autosomal Recessive Type 89 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the KARS1 gene, which are linked to Autosomal Recessive Deafness 89 (DFNB89). This condition is characterized by the impairment of hearing that results from genetic variations inherited from both parents. The test is particularly crucial for families with a history of hearing loss, as it can provide valuable information for early intervention and management strategies.

Performed at DNA Labs UAE, a leading facility in genetic testing, this test involves analyzing the patient’s DNA to detect any abnormalities in the KARS1 gene. The process is meticulous and requires advanced technological tools to ensure accuracy and reliability in the results. Given the complexity and the specialized nature of the test, the cost is set at 4400 AED. This investment covers the comprehensive analysis and the expertise required to interpret the results accurately.

Early detection through the KARS1 Gene Deafness Autosomal Recessive Type 89 Genetic Test can be pivotal for affected individuals and their families. It not only aids in understanding the risk of transmitting the condition to future generations but also opens up avenues for early interventions that can significantly improve the quality of life for those diagnosed with this type of hearing loss.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KARS1 Gene Deafness Autosomal Recessive Type 89 Genetic Test

Cost: AED 4400.0

Symptoms and Diagnosis

KARS1 gene is responsible for encoding the enzyme lysyl-tRNA synthetase, which is crucial for protein synthesis. Mutations in this gene can cause autosomal recessive type 89 (DFNB89) deafness. To diagnose this condition, a genetic test is performed using NGS (Next-Generation Sequencing) technology.

Test Components

  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics

Pre Test Information

Clinical history of the patient is required, especially if they have GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes. A genetic counseling session may be conducted to draw a pedigree chart of family members affected by GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB12.

Test Details

NGS genetic testing is a technique used to analyze multiple genes simultaneously. In the case of KARS1 gene deafness, NGS genetic testing can identify mutations in the KARS1 gene that may be responsible for causing DFNB89. The test involves obtaining a DNA sample, typically through a blood sample or saliva swab. The DNA is then sequenced using NGS technology to detect any variations or mutations in the KARS1 gene. This test provides a definitive diagnosis of DFNB89, which can be useful for genetic counseling and guiding potential treatment options for individuals affected by this type of deafness.

Test Name KARS1 Gene Deafness autosomal recessive type 89 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB12
Test Details

The KARS1 gene is responsible for encoding the enzyme lysyl-tRNA synthetase, which plays a crucial role in protein synthesis. Mutations in this gene can lead to a type of deafness known as autosomal recessive type 89 (DFNB89).

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. In the case of KARS1 gene deafness, NGS genetic testing can identify mutations in the KARS1 gene that may be responsible for causing DFNB89.

This type of genetic test involves obtaining a DNA sample, typically through a blood sample or saliva swab, from the individual being tested. The DNA is then sequenced using NGS technology, which allows for the detection of any variations or mutations in the KARS1 gene.

By identifying specific mutations in the KARS1 gene, NGS genetic testing can provide a definitive diagnosis of DFNB89. This information can be useful for genetic counseling, as well as for guiding potential treatment options or interventions for individuals affected by this type of deafness.

SKU: TEST-2740 Category:

Related products